A PILOT CLINICAL TRIAL TO MONITOR RESPONSE TO CHEMOTHERAPY USING THE CA-62 MARKER OF EPITHELIAL CARCINOMAS

A PILOT CLINICAL TRIAL TO MONITOR RESPONSE TO CHEMOTHERAPY USING THE CA-62 MARKER OF EPITHELIAL CARCINOMAS

The objective of the study was to assess the feasibility of using CA -62 marker of epithelial carcinomas for monitoring treatment response and detecting cancer progression or recurrence during chemotherapy.Material and Methods. A 12-month double-blind clinical trial was conducted by two independent...

Full description

Bibliographic Details
Main Authors:	G. G. Khakimova, Zh. R. Cherkasova, S. A. Tsurkan, G. A. Fedchikov, N. V. Suganov, V. A. Gorbunova
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2019-11-01
Series:	Сибирский онкологический журнал
Subjects:	chemotherapy gastric cancer small-cell lung cancer colorectal cancer neuroendocrine cancer ovarian cancer са-62 cancer antigen immunochemiluminescent assay cancer marker monitoring stable disease disease progression
Online Access:	https://www.siboncoj.ru/jour/article/view/1184

Similar Items

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

Practical application of the CA-62 tumor marker in the initial diagnosis of oncological disease of epithelial origin: assistance to the doctor in interpreting the results
by: Janneta R. Tcherkassova, et al.
Published: (2023-06-01)

A systematic review of primary large cell neuroendocrine carcinoma of the prostate
by: Ngan Nguyen, et al.
Published: (2024-03-01)

SQSTM1/p62 promotes the progression of gastric cancer through epithelial-mesenchymal transition
by: Yan Xu, et al.
Published: (2024-02-01)

Head and neck neuroendocrine tumors at a single institution over 15 years
by: Maria Bacalao, et al.
Published: (2019-12-01)

Exploring NUP62’s role in cancer progression, tumor immunity, and treatment response: insights from multi-omics analysis
by: Lihong Chen, et al.
Published: (2025-03-01)

A Comparative Study for Measuring Serum Ferritin Levels with Three Different Laboratory Methods: Enzyme-Linked Immunosorbent Assay versus Cobas e411 and Cobas Integra 400 Methods
by: Lotfi S. Bin Dahman, et al.
Published: (2022-01-01)

Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
by: Rittu Hingorani, et al.
Published: (2014-11-01)

Neuroendocrine cancer of maxillary sinus: case report and literature review
by: T. I. Deshkina, et al.
Published: (2022-02-01)

Small cell carcinoma with neuroendocrine differentiation of subglottic larynx- a case report
by: Rafał Becht, et al.
Published: (2023-09-01)

Neuroendocrine Carcinomas of the Uterine Cervix, Endometrium, and Ovary Show Higher Tendencies for Bone, Brain, and Liver Organotrophic Metastases
by: Hyung Kyu Park
Published: (2022-10-01)

High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer
by: Eva Philipson, et al.
Published: (2022-03-01)

A case of neuroendocrine carcinoma developing from the broad ligament of the uterus
by: Yui Itonaga, et al.
Published: (2017-07-01)

Insight into the role of p62 in the cisplatin resistant mechanisms of ovarian cancer
by: Xiao-Yu Yan, et al.
Published: (2020-04-01)

Poly C Binding Protein 1 Regulates p62/SQSTM1 mRNA Stability and Autophagic Degradation to Repress Tumor Progression
by: Wenliang Zhang, et al.
Published: (2020-08-01)

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
by: Juan Fernando Sánchez Vega, et al.
Published: (2018-05-01)

Primary Renal Large Cell Neuroendocrine Carcinoma in a Young Man
by: Cornerstone Wann, et al.
Published: (2014-11-01)

Câncer de Pênis em Jovem de 23 Anos associado a infecção Por HPV 62 – relato de caso
by: Julio José M Carvalho, et al.
Published: (2022-01-01)

Cancer Vaccines: Antigen Selection Strategy
by: Yue Zhao, et al.
Published: (2021-01-01)

P62: An emerging oncotarget for osteolytic metastasis
by: Jing Zhang, et al.
Published: (2016-03-01)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
by: Dawn Sijin Nin, et al.
Published: (2023-03-01)

Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
by: Lina Merkens, et al.
Published: (2022-02-01)

Nuclear Medicine and Cancer Theragnostics: Basic Concepts
by: Vasiliki Zoi, et al.
Published: (2023-09-01)

A rare case of rectal adenocarcinoma and small-bowel neuroendocrine tumor in a young patient with long-standing Crohn's disease: A case report
by: Nahla Azzam
Published: (2021-01-01)

Cancer-associated retinopathy secondary to gallbladder carcinoma
by: Goyvaerts, Karel, et al.
Published: (2024-09-01)

Gross Findings of Widespread Visceral Metastasis of Prostatic Adenocarcinoma With Neuroendocrine Features: A Case Report
by: David J. Habibian, et al.
Published: (2016-09-01)

Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics
by: Ilene Le, et al.
Published: (2022-05-01)

Avaliação dos níveis séricos de hormônios tireoidianos em araras (Ara spp.) pelo método de quimioluminescência
by: K.R.A. Vieira, et al.

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
by: Adviti Naik, et al.
Published: (2022-11-01)

Editorial: Recent Advances in Pheochromocytoma and Paraganglioma: Molecular Pathogenesis, Clinical Impacts, and Therapeutic Perspective
by: Farhadul Islam, et al.
Published: (2021-08-01)

Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma
by: Yazarlou F, et al.
Published: (2018-11-01)

CHROMOGRANIN-A IN THE DIAGNOSIS OF PROSTATE CANCER
by: A. V. Sivkov, et al.
Published: (2015-04-01)

PRIMARY NEUROENDOCRINE CARCINOMA OF THE BREAST
by: Ali Harlak, et al.
Published: (2007-07-01)

Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) of the Esophagus: A Case Report
by: Domingo Cristina G, et al.
Published: (2022-11-01)

Neuroendocrine cancer of the prostate. Two case reports
by: Tamás Kullmann, et al.
Published: (2022-03-01)

Mechanisms of castration resistant prostate cancer formation and progression through neuroendocrine differentiation
by: Xueping Ma, et al.
Published: (2021-09-01)

Assessment of serum carcinoembryonic antigen in colorectal cancer patients treated by surgery and chemotherapy
by: Shahbaa A. Al-Bayati
Published: (2011-12-01)

Neuroendocrine carcinoma of the cervix: a systematic review of the literature
by: Clemens B. Tempfer, et al.
Published: (2018-05-01)

Miconazole Contributes to NRF2 Activation by Noncanonical P62-KEAP1 Pathway in Bladder Cancer Cells
by: Tsai TF, et al.
Published: (2020-03-01)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
by: Adrian von Witzleben, et al.
Published: (2020-09-01)